Manufacturer record

Urbofort SGNR (RAJ): regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Urbofort SGNR (RAJ) was declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: URJA702, Urja Urbpro Capsule (exp Apr 2029). FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra State (state lab) found it not of standard quality: The Sample gives TLC And HPLC Identification Test for the Presence of Tadalafil. Found Content of Tadalafil: 8.67 mg Per Capsule. Hence, the. Listed in the September 2026 alert.

Records by type

1 record linked to Urbofort SGNR (RAJ) in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2026 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2026
1
Products affected
Identification
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Urja Urbpro Capsule Batch URJA702Mfg May 2026 · Exp Apr 2029 The Sample gives TLC And HPLC Identification Test for the Presence of Tadalafil. Found Content of Tadalafil: 8.67 mg Per Capsule. Hence, the Sample is declared as Spurious Vide Section 33-EEA(d) of Drugs And Cosmetics Act 1940 And Rules thereunder.Identification FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab Sep 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.